Results summary | View all lists in GO:BiolProc | View all genes in D07AB.profile.ud50 |
A biological process whose specific outcome is the progression of an integrated living unit: a cell, tissue, organ, or organism over time from an initial condition to a later condition. enrichment: 1.52-fold |
|||||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
210260_S_AT | TNFAIP8 | G | tumor necrosis factor, alpha-induced protein 8 | ||||||||||
215073_S_AT | NR2F2 | D | E | R | S | nuclear receptor subfamily 2, group F, member 2 | |||||||
204334_AT | KLF7 | D | R | Kruppel-like factor 7 (ubiquitous) | |||||||||
207499_X_AT | UNC45A | D | P | unc-45 homolog A (C. elegans) | |||||||||
210538_S_AT | BIRC3 | G | S | baculoviral IAP repeat-containing 3 | |||||||||
203140_AT | BCL6 | G | D | X | R | C | S | B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||||
207826_S_AT | ID3 | D | R | inhibitor of DNA binding 3, dominant negative helix-loop-helix protein | |||||||||
213139_AT | SNAI2 | D | R | C | snail homolog 2 (Drosophila) | ||||||||
217997_AT | PHLDA1 | G | pleckstrin homology-like domain, family A, member 1 | ||||||||||
212501_AT | CEBPB | G | D | X | P | R | CCAAT/enhancer binding protein (C/EBP), beta | ||||||
214439_X_AT | BIN1 | G | T | D | bridging integrator 1 | ||||||||
34697_AT | LRP6 | T | D | S | low density lipoprotein receptor-related protein 6 | ||||||||
209357_AT | CITED2 | D | R | S | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | ||||||||
205945_AT | IL6R | G | D | X | S | interleukin 6 receptor | |||||||
209185_S_AT | IRS2 | G | D | E | S | insulin receptor substrate 2 | |||||||
217996_AT | PHLDA1 | G | pleckstrin homology-like domain, family A, member 1 | ||||||||||
219884_AT | LHX6 | D | R | LIM homeobox 6 | |||||||||
207980_S_AT | CITED2 | D | R | S | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | ||||||||
203542_S_AT | KLF9 | D | R | S | Kruppel-like factor 9 | ||||||||
202936_S_AT | SOX9 | D | R | C | SRY (sex determining region Y)-box 9 (campomelic dysplasia, autosomal sex-reversal) | ||||||||
209099_X_AT | JAG1 | G | D | S | jagged 1 (Alagille syndrome) | ||||||||
205409_AT | FOSL2 | R | FOS-like antigen 2 | ||||||||||
217618_X_AT | HUS1 | G | D | X | P | HUS1 checkpoint homolog (S. pombe) | |||||||
218559_S_AT | MAFB | D | R | v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) | |||||||||
205926_AT | IL27RA | D | X | S | interleukin 27 receptor, alpha | ||||||||
201502_S_AT | NFKBIA | G | T | D | S | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | |||||||
201341_AT | ENC1 | D | ectodermal-neural cortex (with BTB-like domain) | ||||||||||
208961_S_AT | KLF6 | D | R | S | Kruppel-like factor 6 | ||||||||
210355_AT | PTHLH | G | D | C | S | parathyroid hormone-like hormone | |||||||
209184_S_AT | IRS2 | G | D | E | S | insulin receptor substrate 2 | |||||||
205032_AT | ITGA2 | D | X | C | S | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | |||||||
39402_AT | IL1B | G | X | P | C | S | interleukin 1, beta |